Dimensional Fund Advisors LP Reduces Stock Position in Cabot Co. (NYSE:CBT)

Dimensional Fund Advisors LP cut its stake in Cabot Co. (NYSE:CBT - Free Report) by 1.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,318,296 shares of the specialty chemicals company's stock after selling 19,534 shares during the quarter. Dimensional Fund Advisors LP owned 2.43% of Cabot worth $120,373,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. R Squared Ltd bought a new position in Cabot during the 4th quarter valued at $26,000. EverSource Wealth Advisors LLC raised its holdings in shares of Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after purchasing an additional 219 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Cabot by 10.7% during the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after purchasing an additional 130 shares in the last quarter. Manchester Capital Management LLC boosted its holdings in Cabot by 1,685.1% during the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after purchasing an additional 1,584 shares during the last quarter. Finally, KBC Group NV grew its position in Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock worth $187,000 after purchasing an additional 616 shares in the last quarter. Institutional investors own 93.18% of the company's stock.

Cabot Stock Performance

NYSE CBT traded down $0.17 on Wednesday, hitting $78.55. 587,896 shares of the stock traded hands, compared to its average volume of 392,896. The firm has a market capitalization of $4.26 billion, a price-to-earnings ratio of 10.43, a PEG ratio of 0.74 and a beta of 1.04. The business's fifty day moving average is $81.60 and its two-hundred day moving average is $93.24. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. Cabot Co. has a 12 month low of $73.63 and a 12 month high of $117.46.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, equities analysts anticipate that Cabot Co. will post 7.57 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. UBS Group cut their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. StockNews.com upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th. Mizuho lowered their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.